Telix has announced a new clinical collaboration with Varian.

Telix 宣布与 Varian 达成新的临床合作。

The partnership aims to develop new clinical approaches that bring together Telix’s theranostic products with external beam radiation therapy (EBRT).

该合作伙伴关系旨在开发新的临床方法，将Telix的诊疗产品与外照射放射治疗（EBRT）结合起来。

EBRT is a well-established treatment used for many solid tumours and is delivered by radiation oncologists who guide patients through different stages of cancer care. Telix and Varian plan to explore how integrating therapeutic radiopharmaceuticals and precision imaging could support better patient selection and more targeted treatment within radiation oncology..

EBRT 是一种成熟的治疗方法，广泛应用于多种实体瘤，由放射肿瘤科医生负责实施，他们引导患者度过癌症治疗的不同阶段。Telix 和 Varian 计划探索如何整合治疗性放射性药物和精准成像技术，以支持更好的患者选择和更精准的放射肿瘤治疗方案。

The first area of investigation focuses on prostate cancer. The companies will assess how PSMA-PET imaging and Telix products such as Gozellix® and Illuccix® could help identify suitable patients for EBRT, support personalised treatment planning, including adaptive radiotherapy, and monitor treatment outcomes.

第一项研究领域聚焦于前列腺癌。这些公司将会评估PSMA-PET成像以及Telix的产品（如Gozellix®和Illuccix®）如何帮助识别适合接受EBRT治疗的患者，支持个性化治疗规划（包括自适应放疗），并监测治疗效果。

The collaboration includes both company-sponsored and investigator-led studies to encourage extensive clinical evaluation..

该合作包括公司赞助和研究者主导的研究，以鼓励广泛的临床评估。

Although the initial work centres on PSMA imaging, the agreement provides a broader framework for future joint development. This could involve other PET imaging candidates in Telix’s pipeline, including TLX250-CDx (Zircaix®) and TLX101-CDx (Pixclara®), along with potential therapeutic radiopharmaceuticals.

尽管最初的工作集中在PSMA成像上，但该协议为未来的联合开发提供了更广泛的框架。这可能涉及Telix公司产品线中的其他PET成像候选产品，包括TLX250-CDx（Zircaix®）和TLX101-CDx（Pixclara®），以及潜在的治疗性放射性药物。

The companies believe that combining radiopharmaceutical theranostics with Varian’s EBRT technology could strengthen the role of radiation oncologists in both definitive and palliative cancer treatment..

这些公司认为，将放射性药物治疗与瓦里安的外照射放疗技术相结合，可以加强放射肿瘤科医生在根治性和姑息性癌症治疗中的作用。

The collaboration is expected to support the long-term development of more precise, patient-focused cancer care by aligning molecular imaging with advanced radiation therapy.

通过将分子影像与先进的放射治疗相结合，预计将支持更精准、以患者为中心的癌症护理的长期发展。

Source: telixpharma.com

来源：telixpharma.com